Your rights in Crescentis Capital.
Check your entitlement, read the offer, and apply by 27 November 2026.
Opens 16 November 2026 — in 6 days. Closes 27 November 2026.
-
Step 1
Check your Rights Entitlement
-
Step 2
Read the Letter of Offer and your Rights Entitlement Letter
Crescentis Capital sends your Rights Entitlement Letter and the Application Form to your registered e-mail address or, without one, to your Indian address.
-
Step 3
Apply through your bank by 27 November 2026
Applications are made only through ASBA: your bank, a Self-Certified Syndicate Bank (SCSB), blocks the application money in your account. Submit the Application Form at a Designated Branch of your SCSB, or apply on its website where it offers that.
-
Step 4 · Physical shares only
Give us your demat details by 24 November 2026
Rights Entitlements are credited in demat form only. Register your demat account with us — your folio, one certificate number and your client master list — and we move your Rights Entitlement into it.
Applying on plain paper
If the Application Form has not reached you and you cannot get it elsewhere, you can apply on plain paper. The Letter of Offer sets out what the application must contain:
Making of an Application by Eligible Equity Shareholders on Plain Paper under ASBA process
An Eligible Equity Shareholder in India who is eligible to apply under the ASBA process may make an application to subscribe to this Issue on plain paper in terms of Regulation 78 of SEBI ICDR Regulations in case of non-receipt of Application Form as detailed above. In such cases of non-receipt of the Application Form through e-mail or physical delivery (where applicable) and the Eligible Equity Shareholder not being in a position to obtain it from any other source may make an application to subscribe to this Issue on plain paper with the same details as per the Application Form that is available on the website of the Registrar or Stock Exchange. An Eligible Equity Shareholder shall submit the plain paper Application to the Designated Branch of the SCSB for authorising such SCSB to block Application Money in the said bank account maintained with the same SCSB. Applications on plain paper will not be accepted from any Eligible Equity Shareholder who has not provided an Indian address or is a U.S. Person or in the United States.
Additionally, in terms of Regulation 78 of the SEBI ICDR Regulations, Investors may choose to accept the offer to participate in this Issue by making plain paper Applications. Please note that SCSBs shall accept such applications only if all details required for making the application as per the SEBI ICDR Regulations are specified in the plain paper application. If an Eligible Equity Shareholder makes an application both in an Application Form as well as on plain paper, both applications are liable to be rejected.
Please note that terms of Regulation 78 of SEBI ICDR Regulations, the Eligible Equity Shareholders who are making the Application on plain paper shall not be entitled to renounce their Rights Entitlements and should not utilize the Application Form for any purpose including renunciation even if it is received subsequently.
The Application on plain paper, duly signed by the Eligible Equity Shareholder including joint holders, in the same order and as per specimen recorded with his/her bank, must reach the office of the Designated Branch of the SCSB before the Issue Closing Date and should contain the following particulars:
- Name of the Issuer Company, being Crescentis Capital Limited.
- (i) Name and address of the Eligible Equity Shareholder including joint holders (in the same order and as per specimen recorded with our Company or the Depository);
- (ii) Folio Number (in case of Eligible Equity Shareholders who hold Equity Shares in physical form as on Record Date)/DP and Client ID;
- (iii) Except for Applications on behalf of the Central or State Government, the residents of Sikkim and the officials appointed by the courts, PAN of the Eligible Equity Shareholder and for each Eligible Equity Shareholder in case of joint names, irrespective of the total value of the Equity Shares applied for pursuant to this Issue
- (iv) Number of Equity Shares held as on Record Date;
- (v) Allotment option – only dematerialised form;
- (vi) Number of Equity Shares entitled to;
- (vii) Number of Equity Shares applied for within the Rights Entitlements;
- (viii) Number of additional Equity Shares applied for, if any (applicable only if entire Rights Entitlements have been applied for);
- (ix) Total number of Equity Shares applied for;
- (x) Total amount paid at the rate of ₹78/- per Equity Share;
- (xi) Details of the ASBA Account such as the SCSB account number, name, address and branch of the relevant SCSB;
- (xii) In case of non-resident Eligible Equity Shareholders making an application with an Indian address, details of the NRE/FCNR/NRO account such as the account number, name, address and branch of the SCSB with which the account is maintained;
- (xiii) Authorisation to the Designated Branch of the SCSB to block an amount equivalent to the Application Money in the ASBA Account;
- (xiv) Signature of the Eligible Equity Shareholder (in case of joint holders, to appear in the same sequence and order as they appear in the records of the SCSB); and
- (xv) An approval obtained from any regulatory authority, if required, shall be obtained by the Eligible Equity Shareholders and a copy of such approval from any regulatory authority, as may be required, shall be sent to the Registrar at the registered office address given on the cover page; and
- (xvi) All such Eligible Equity Shareholders shall be deemed to have made the representations, warranties and agreements set forth in “Restrictions on Purchases and Resales - Representations, Warranties and Agreements by Purchasers” on page 117, and shall include the following:
“I/We understand that neither the Rights Entitlement nor the Rights Equity Shares have been or will be registered under the U.S. Securities Act of 1933 as amended (the U.S. Securities Act or any United States state securities laws, and may not be offered, sold, resold or otherwise transferred within the United States or to the territories or possessions thereof (the “United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the U.S. Securities Act. I/we understand the Rights Equity Shares referred to in this application are being offered and sold in offshore transactions outside the United States in compliance with Regulation S under the U.S. Securities Act (“Regulation S”) to Eligible Equity Shareholders located in jurisdictions where such offer and sale of the Rights Equity Shares is permitted under laws of such jurisdictions. I/we understand that the Issue is not, and under no circumstances is to be construed as, an offering of any Rights Equity Shares or Rights Entitlements for sale in the United States, or as a solicitation therein of an offer to buy any of the said Rights Equity Shares or Rights Entitlements in the United States. I/we confirm that I am/ we are (a) not in the United States and eligible to subscribe for the Rights Equity Shares under applicable securities laws, (b) complying with laws of jurisdictions applicable to such person in connection with the Issue, and (c) understand that neither the Company, nor the Registrar or any other person acting on behalf of the Company will accept subscriptions from any person, or the agent of any person, who appears to be, or who the Company, the Registrar or any other person acting on behalf of the Company have reason to believe is in the United States or is outside of India and ineligible to participate in this Issue under the securities laws of their jurisdiction.
I/ We will not offer, sell or otherwise transfer any of the Rights Equity Shares which may be acquired by us in any jurisdiction or under any circumstances in which such offer or sale is not authorized or to any person to whom it is unlawful to make such offer, sale or invitation except under circumstances that will result in compliance with any applicable laws or regulations. We satisfy, and each account for which we are acting satisfies, all suitability standards for Shareholders in investments of the type subscribed for herein imposed by the jurisdiction of our residence.
I/ We understand and agree that the Rights Entitlement and Rights Equity Shares may not be reoffered, resold, pledged or otherwise transferred except in an offshore transaction in compliance with Regulation S, or otherwise pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the U.S. Securities Act.
I/ We (i) am/ are, and the person, if any, for whose account I/ we am/ are acquiring such Rights Entitlement and/or the Rights Equity Shares is/ are, outside the U.S., (ii) am/ are not a “U.S. Person” as defined in (“Regulation S”), and (iii) is/ are acquiring the Rights Entitlement and/or the Rights Equity Shares in an offshore transaction meeting the requirements of Regulation S.
I/we hereby make the representations, warranties, acknowledgments and agreements set forth in the section of the Letter of Offer titled “Restrictions on Purchases and Resales” on page 117.
I/ We acknowledge that the Company, its affiliates and others will rely upon the truth and accuracy of the foregoing representations and agreements.”
In cases where Multiple Application Forms are submitted for Applications pertaining to Rights Entitlements credited to the same demat account or in demat suspense escrow account, as applicable, including cases where a Shareholders submits Application Forms along with a plain paper Application, such Applications shall be liable to be rejected.
Shareholders are requested to strictly adhere to these instructions. Failure to do so could result in an application being rejected, with our Company and the Registrar not having any liability to the Shareholders. The plain paper Application format will be available on the website of the Registrar at www.rcmcdelhi.com.
Our Company and the Registrar shall not be responsible if the Applications are not uploaded by the SCSB or funds are not blocked in the Shareholders’ ASBA Accounts on or before the Issue Closing Date.
Shareholders outside India
Crescentis Capital sends the Rights Entitlement Letter and Application Form only to an Indian address. If the laws where you live allow you to subscribe, e-mail us a self-attested PAN, your client master sheet and your demat account details. Pay only through ASBA, from an account FEMA and RBI rules permit, such as NRE, FCNR or NRO.
Frequently asked questions
These answers summarise the Letter of Offer dated 3 November 2026. Read it before you apply.
The issue at a glance
What is this rights issue?
Crescentis Capital Limited (CCL), formerly Som Datt Finance Corporation Limited, offers 1,02,08,129 fully paid-up Rights Equity Shares of face value ₹10 each, at ₹78 per share including a premium of ₹68. Shareholders on the record date, 4 November 2026, are offered 3 Rights Equity Shares for every 5 fully paid-up equity shares they hold. The issue raises ₹7,962.34 lakh, assuming full subscription. CCL’s shares are listed on BSE.
Who can apply?
Shareholders whose names appear as beneficial owners with the depositories, or on CCL’s register of members for physical shares, at the close of business on the record date, 4 November 2026. Anyone who buys or receives Rights Entitlements — a renouncee — can also apply, against the Rights Entitlements in their demat account.
What are the key dates?
- Rights Entitlements credited to demat accounts: by 11 November 2026
- Issue opens: 16 November 2026
- Last day to sell Rights Entitlements on BSE: 20 November 2026
- Physical shareholders’ demat details due with RCMC: 24 November 2026
- Issue closes: 27 November 2026
- Basis of allotment: on or about 30 November 2026
- Allotment: on or about 1 December 2026
- Rights Equity Shares credited: on or about 2 December 2026
- Listing and trading: on or about 3 December 2026
CCL’s Board can extend the issue period, to no more than 30 days from the opening date.
How much do I pay?
₹78 per Rights Equity Share — the face value of ₹10 plus a premium of ₹68 — in full, on application.
How many Rights Equity Shares can I apply for?
Your Rights Entitlement Letter shows the number: 3 for every 5 shares you held on the record date. Fractions are ignored. If a fraction of yours was ignored, you get preference for one additional share when you apply for additional shares.
Where can I read the Letter of Offer?
On this page and on BSE’s website (www.bseindia.com). CCL sends the Application Form and Rights Entitlement Letter to every shareholder with an Indian address — by e-mail where one is registered, otherwise, on a reasonable-effort basis, to the Indian address on record. The Letter of Offer itself is sent to shareholders with an Indian address who ask for it.
Rights Entitlements
What is a Rights Entitlement?
Your right to subscribe to the Rights Equity Shares set out in your Rights Entitlement Letter. CCL credits it to your demat account before the issue opens — by 11 November 2026 — in demat form only, under its own ISIN: INE754C20028.
How do I check my Rights Entitlement online?
Use the Rights Entitlement check on this page. For shares in demat form, enter your DP ID and Client ID and the PAN of the first holder — the holder named first on the demat account. For shares in physical form, enter your folio number and the certificate number of any one share certificate in that folio. The check shows only your own record.
Can I sell or transfer my Rights Entitlements?
Yes, in full or in part, once they are in your demat account:
- On BSE, through your stock broker, from 16 November 2026 to 20 November 2026, quoting ISIN INE754C20028. The market lot is one Rights Entitlement.
- Off-market, through your depository participant, with a delivery instruction slip quoting the same ISIN, INE754C20028. Complete it in time for the Rights Entitlements to reach the buyer’s demat account by the issue closing date, 27 November 2026.
Resident shareholders who held physical shares on the record date cannot renounce. Nor can anyone who applies on plain paper.
What happens if I neither apply nor sell?
Your Rights Entitlements lapse when the issue closes on 27 November 2026 and are extinguished. You get no shares for them. A buyer of Rights Entitlements who does not apply loses the premium paid for them.
I bought Rights Entitlements. Do I still need to apply?
Yes. A Rights Entitlement is the right to apply, not a share. Apply through ASBA by the issue closing date, or the Rights Entitlements lapse and the premium you paid is lost.
Applying
How do I apply?
Only through ASBA (Application Supported by Blocked Amount). You need an ASBA-enabled bank account with a Self-Certified Syndicate Bank (SCSB). Submit the Application Form at a Designated Branch of your SCSB, or apply on the SCSB’s website where it offers that. The SCSB blocks the application money in your account until the basis of allotment is final. SEBI publishes the list of SCSBs on its website.
What can I do with my Rights Entitlements when I apply?
You have five options:
- apply for all of them;
- apply for part, without renouncing the rest;
- apply for part and renounce the rest;
- apply for all of them, and for additional shares;
- renounce them in full.
Can I apply for more shares than my entitlement?
Yes, if you apply for your full Rights Entitlement and renounce none of it. If more additional shares are applied for than are available, they are allotted on the basis of allotment that CCL finalises with BSE. If you renounce any Rights Entitlements, you cannot apply for additional shares.
I have not received the Application Form. How do I apply?
Download it from this page or from BSE’s website (www.bseindia.com) — or apply on plain paper, using the plain-paper format on this page. All holders sign it, in the same order as their bank’s specimen, and it must reach the Designated Branch of your SCSB before the issue closes. A plain-paper application cannot renounce Rights Entitlements, and SCSBs do not accept one from a shareholder without an Indian address. Never send both the form and a plain-paper application — both can be rejected.
Can I pay in cash, by cheque, or from someone else’s bank account?
No. Every payment goes through ASBA, and the Registrar accepts no other payment. You cannot apply from a third party’s ASBA account.
Can I hand my application to RCMC or to CCL?
No. Submit it only to a Designated Branch of your SCSB, or online through your SCSB. Do not send it to RCMC, to CCL, to the escrow collection bank or to a branch that is not a Designated Branch.
Which details must match to avoid rejection?
Your DP ID, Client ID and PAN must be correct: an application with wrong depository details or PAN is rejected. Give the PAN of every joint holder, and make sure your PAN is linked with Aadhaar. Names must be exactly as in your demat account, in the same order. Make one application per demat account — multiple applications can be rejected.
What is the last time to apply?
5.00 p.m. (IST) on 27 November 2026, the issue closing date — unless BSE permits a later time or CCL’s Board extends the issue. Apply before the closing date: on the day itself, delays can stop a physical application.
Can I withdraw my application?
Yes, at any time while the issue is open, through the SCSB where you applied. After the issue closes on 27 November 2026, no application can be withdrawn.
Shareholders with physical share certificates
I hold shares in physical form. What do I do?
Rights Entitlements are credited in demat form only. Until RCMC has your demat account details, yours are held in CCL’s demat suspense escrow account. Give RCMC your demat details by 24 November 2026, in one of two ways:
- online, through “Register your demat details” on this page; or
- by letter to RCMC — by e-mail to investor.services@rcmcdelhi.com, or by post, speed post, courier or hand — with your name, address, e-mail, contact details and demat account details, a self-attested PAN and a self-attested client master sheet.
RCMC verifies the account and moves your Rights Entitlements into it at least one day before the issue closes. Apply once they arrive. If you are resident in India, you cannot renounce them, but you can apply for additional shares.
Shareholders outside India
I live outside India. How do I take part?
CCL sends the Rights Entitlement Letter and Application Form only to an Indian address. If the laws where you live allow you to subscribe, download the Letter of Offer and Application Form from this page or from BSE’s website. To update your Indian address, e-mail investor.services@rcmcdelhi.com a self-attested proof of address or passport; use the same address to send a self-attested PAN, your client master sheet and your demat account details. Pay only through ASBA, from an account FEMA and RBI rules permit, such as NRE, FCNR or NRO. SCSBs do not accept a plain-paper application from a shareholder without an Indian address.
After the issue closes
When do I get my shares, or my money back?
On or about these dates: basis of allotment, 30 November 2026; allotment, 1 December 2026; Rights Equity Shares credited to your demat account, 2 December 2026; listing and trading on BSE, 3 December 2026. Shares are allotted in demat form only. Application money not used for allotted shares is unblocked in your ASBA account.
Help with this issue
Whom do I contact with a query?
RCMC Share Registry Private Limited, Registrar to the Issue — Mr. Murli Dharan Nair. RCMC runs this issue’s dedicated helpdesk:
- Helpline: 8527695125
- E-mail: investor.services@rcmcdelhi.com
- Post: B-25/1, Okhla Industrial Area, Phase-II, New Delhi 110020
The helpline box on this page lists RCMC’s other numbers for this issue. Quote your folio number, or DP ID and Client ID; your Application Form number; and the first holder’s name. Mark the envelope or e-mail “CRESCENTIS CAPITAL LIMITED – Rights Issue”.